Streetbeat News

Equity Actions

DNLI

Denali Therapeutics Inc has filed a prospectus with the SEC for the offer and resale of up to 29.3 million shares by selling stockholders. This move could potentially impact the company's stock price due to the increase in available shares.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 8:05 pm

HXL

Hexcel Corporation has filed with the SEC for a potential mixed shelf offering, though the size of the offering has not been disclosed. This move allows Hexcel to sell various types of securities over time, providing flexibility in financing its operations or growth initiatives.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 8:04 pm

STVN

Stevanato Group S.P.A. has seen its shares trading higher following the pricing of an upsized public offering of 12.7 million shares at $26 per share.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 7:47 pm

SUP

Centerview Partners is in talks with private credit lenders to refinance Superior Industries International Inc.'s (SUP) outstanding debt. The aim is to refinance approximately €250 million ($270 million) of unsecured bonds due in 2025, alongside about $250 million of redeemable preferred stock. This move is part of efforts to manage the autoparts maker's upcoming debt maturities.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 7:34 pm

MAIA

MAIA Biotechnology, Inc. (NYSE:MAIA) announced a private placement of common stock and warrants, raising approximately $2.9 million. Independent director Stan V. Smith, Ph.D., purchased 170,940 shares, highlighting his confidence in MAIA's cancer therapies. The placement involved the sale of 2,043,587 shares at $1.17 each. This move underscores the directors' belief in MAIA's innovative approach to targeting difficult-to-treat cancers.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 7:01 pm

FDS

FactSet Research Systems (NYSE:FDS) received mixed analyst ratings with 3 indifferent and 1 bearish over the past three months. The average 12-month price target is $453.0, reflecting a 5.72% increase from the previous $428.50. Analyst actions include maintaining, raising, and lowering ratings with price targets adjusted accordingly. FactSet's financial performance shows positive revenue growth, high net margin, ROE, and ROA, but faces challenges in market capitalization and debt management.

Portfolio Pulse from Benzinga Insights

March 22, 2024 | 7:00 pm

ARKK

COIN

SARK

Coinbase Global, Inc (NASDAQ:COIN) reached a 27-month high of $276.38, showing strength despite a retracement in Bitcoin and Ethereum. JMP analyst Devin Ryan maintained a $300 price target for Coinbase, highlighting its growth prospects. Meanwhile, Ark Invest sold 199,526 Coinbase shares through ARKK, ARKW, and ARKF. Traders bearish on ARKK may consider SARK, which shorts disruptive innovation. Coinbase's stock is forming a potential bull flag pattern, indicating a possible uptrend towards $318.

Portfolio Pulse from Melanie Schaffer

March 22, 2024 | 6:54 pm

YOU

CLEAR announced a special cash dividend and an increase in its share repurchase authorization, leading to a rise in its stock price.

Portfolio Pulse from Benzinga Newsdesk

March 22, 2024 | 6:27 pm

DPZ

PZZA

Papa John's CEO Rob Lynch is set to depart on April 30, surprising analysts given his role in the company's recovery. BMO Capital Markets analyst Andrew Strelzik lowered Papa John's (PZZA) price target from $90 to $80, citing leadership changes and competitive pressures. The departure raises questions about the company's future initiatives and performance. Despite near-term challenges, the long-term outlook remains positive, with the company seen as undervalued.

Portfolio Pulse from Shivani Kumaresan

March 22, 2024 | 6:27 pm

AI

Recent options trading trends for C3.ai (NYSE:AI) show a bearish sentiment among financial giants, with 62% of trades indicating bearish tendencies. The trading activity suggests a target price range of $22.5 to $35.0 for C3.ai. Notable options activity includes both bullish and bearish trades with varying expiration dates and strike prices. C3.ai, an enterprise AI company, is currently trading at $28.09, with a slight decrease of -1.02%. Analyst ratings from Piper Sandler, B of A Securities, and Canaccord Genuity offer mixed views, with target prices ranging from $20 to $33.

Portfolio Pulse from Benzinga Insights

March 22, 2024 | 6:16 pm